Dr. Roneet Lev
Dr. Roneet Lev
Episode #183 High Truths on Drugs and Addiction and Dr. Douglas Roehler on CDC Cannabis Unit
Episode #183 High Truths on Drugs and Addiction and Dr. Douglas Roehler on CDC Cannabis Unit
Episode #183 High Truths on Drugs and Addiction and Dr. Douglas Roehler on CDC Cannabis Unit
Monday 24th June 2024
Explore the CDC's cannabis strategy with Dr. Douglas Roehler. Learn about surveillance, research, and prevention efforts in this insightful episode.
68 minutes
Informative
Educational
Supportive
Honest
Engaging
About this podcast
Author:
Dr. Roneet Lev
Overview:
Categories:
Understanding Addiction & Recovery
Navigating Alcohol Dependency
Family Recovery from Addiction
Navigating Intimate Relationships
Body & Mind
Links:
Visit site
Episodes:
195 (View all)
Do you want to link to this podcast?
Get the buttons here!Inside the CDC's Cannabis Strategy: A Conversation with Dr. Douglas Roehler
Episode Overview
- The CDC's Cannabis Strategy Unit focuses on expanding surveillance and research.
- Distinguishing between THC and CBD products is crucial for accurate data.
- Collaboration with federal agencies helps address gaps in cannabis research.
- Delta-8 products pose significant risks due to lack of regulation.
- Accurate data collection is essential for designing effective interventions.
We realised there wasn't any place at CDC that was specifically focusing on drug prevention.
Ever wondered how the CDC tackles cannabis-related issues? In this episode of 'High Truths on Drugs and Addiction', Dr. Roneet Lev sits down with Dr. Douglas Roehler, a Health Scientist for the CDC's Cannabis Strategy Unit. They dive into the CDC's efforts to coordinate and implement a comprehensive cannabis strategy, focusing on expanding surveillance and research. Dr.
Roehler shares his journey from road safety to drug overdose prevention and explains how the CDC's Cannabis Strategy Unit was born out of a need to centralise cannabis-related efforts within the agency. Dr. Roehler discusses the challenges of cannabis surveillance, including the importance of distinguishing between THC and CBD products. He also highlights the unit's work with various federal agencies to ensure resources are used effectively and to address gaps in cannabis research and regulation.
The conversation touches on real-world impacts, such as the rise of Delta-8 products and their associated risks, and the importance of accurate data collection to design safer environments and interventions. The episode is packed with valuable insights for anyone interested in public health, cannabis regulation, or drug prevention strategies. Dr. Roehler's expertise and passion for injury prevention shine through as he shares both successes and ongoing challenges in the field.
Whether you're a healthcare professional, a policy-maker, or simply curious about how the CDC is addressing cannabis-related issues, this episode offers a comprehensive look into the complexities of cannabis strategy at a national level. Tune in to learn how the CDC is making strides in cannabis research and prevention, and why this work is crucial for public health. Don't miss out on this enlightening conversation that sheds light on an often misunderstood topic.